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TYPE II COLLAGEN PEPTIDE ACTIVATES AKT LEADING TO NF-kB UP-
REGULATION IN OSTEOARTHRITIC CHONDROCYTES
T. Yasuda. Kobe City Med. Ctr. Gen. Hosp., Kobe, Japan
Background of this study: In addition to the proinﬂammatory cyto-
kines, degradation products of cartilage matrix are thought to con-
tribute to joint destruction in osteoarthritis (OA). Excessive degradation
of cartilage matrix in OA involves enhanced cleavage of type II collagen
by collagenases, resulting in denaturation of the triple helix of this
collagen. Denatured and degraded type II collagen leads to an increase
in proteolytic products of type II collagen. Recently, we have found that
a 24-mer synthetic peptide of type II collagen named CB12-II stimulates
type II collagen cleavage with induction of matrix metalloproteinase
(MMP)-13 in association with nuclear factor-kB (NF-kB) activation.
However, intracellular upstream events that cause NF-kB up-regulation
in response to CB12-II remain unclear.
The aim of this study: Akt is a serine/threonine protein kinase that
regulates cell survival signals in response to growth factors and
cytokines. Akt is activated via the phosphoinositide-3-OH kinase
(PI3K) pathway, an important pathway regulating immunity
and inﬂammation. Accumulating evidence indicates that Akt
could stimulate signaling pathways that up-regulate the activity of
NF-kB. Therefore, this study was aimed to elucidate the involvement
of PI3K/Akt pathway in NF-kB activation by CB12-II in OA
chondrocytes.
Methods: OA cartilage specimens were obtained from the distal femur
from patients undergoing total knee replacement surgery. Chon-
drocytes isolated from the OA articular cartilage were cultured in
monolayer with CB12-II. Secreted levels of MMP-13 in conditioned
media were determined with enzyme-linked immunosorbent assay
(ELISA). The cell lysates were used to detect endogenous levels of
phosphorylated Akt and phosphorylated p65 NF-kB by ELISA.
Results: In OA chondrocyte monolayer cultures, CB12-II stimulated
MMP-13 production in associationwith up-regulation of NF-kB and Akt.
Inhibition studies using BAY11-7085 conﬁrmed that MMP-13 pro-
duction by CB12-II was dependent on NF-kB pathway. Similarly,
inhibition studies using LY294002 revealed that MMP-13 production by
CB12-II was dependent on PI3K/Akt pathway. When OA chondrocytes
were preincubated with LY294002, CB12-II-induced levels of phos-
phorylated p65 NF-kB were signiﬁcantly decreased. Thus, NF-kB acti-
vation leading to MMP-13 production requires PI3K/Akt pathway in
CB12-II-stimulated chondrocytes.
Conclusions: This is the ﬁrst study demonstrating that the type II col-
lagen-derived peptide, CB12-II, activates PI3K/Akt pathway leading to
up-regulation of NF-kB. Elucidation of intracellular pathways activated
by type II collagen fragments may be helpful to understand the
pathological process in OA cartilage destruction.
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HYPERCHOLESTEROLEMIA IS A METABOLIC RISK FACTOR FOR
OSTEOARTHRITIS
S. Farnaghi. Inst. of Hlth. and bioMed. innovation, Brisbane, Australia
Purpose: A growing body of evidence suggests that osteoarthritis (OA)
is rather a “metabolic disorder” in which various interrelated metabolic
mediators contribute to the initiation and progression of the disease
process. One such metabolic risk factor could be high cholesterol levels
in the body. The primary objective of this study is to delineate how
abnormal cholesterol levels effects the cartilage biology and its relation
to OA development. Further, in this study we tested whether hyper-
cholesterolemia -induced mitochondrial DNA (mtDNA) damage con-
tributed to increased oxidative stress, mitochondrial dysfunction and
chondrocyte apoptosis.
Methods: We investigate the expression of genes regulating cholesterol
efﬂux (NR1H3 and ABCA1) and inﬂux (SREBF-2 and NPC1L1) in human
chondrocytes that were isolated and graded according to the disease
severity from the patients who were undergoing knee replacement
surgeries. The effect of mtDNA damage on the mRNA expression of
respiratory chain subunits, change of mitochondrial membrane
potential (Djm), overproduction of ROS, and apoptosis were assessed in
high cholesterol-treated ACCs by qRT-PCR, ﬂow cytometry, and confocal
microscopy. The effects of high cholesterol treatment on the human and
bovine cartilage explants were assessed by proteoglycan synthesis and
various biochemical assays.Results: In OA ACCs intracellular levels of cholesterol were higher com-
pared to control group. Furthermore, OA ACCs showed dysregulation of
the balance between cholesterol inﬂux and efﬂux genes. Expression of
cholesterol inﬂuxgenes (SREBF-2 andNPC1L1)were increased inOAACCs
compared to control group. On the other hand, expression of cholesterol
efﬂux genes, ABCA1 and NR1H3 were decreased in OA ACCs (Figure 1A).
We then demonstrated that mtDNA oxidative damage increased rapidly
after high cholesterol (300mM). Accordingly, treatment with high cho-
lesterol resulted in decreasedmembrane potential and overproduction of
ROS inACCs (P< 0.05) and apoptosis (Figure 1B). Interestingly, cholesterol
(300mM) treatment of cartilage explants culture showed an extensive
proteoglycan loss (Figure 1C).MTTanalysis showed thatmetabolic activity
of ACCs was gradually decreased with ascending dose of cholesterol (50,
300, 600mM) stimulation. Protein and mRNA expression level of MMP-13
were increased in cholesterol-stimulated group compared to control;
however, COL2A1 showed different expression trend after cholesterol
treatment. Both protein and mRNA expression level of COL2A1 were
increased in treatment group compared to control (Figure 1C).
Conclusion: mtDNA oxidative damage seems to be the “trigger” for cell
dysfunction in high cholesterol-challenged ACCs by setting in motion
the vicious circle of mtDNA damage leading to ROS overproduction and
further apoptosis resulting in the development of abnormalities that
resemble characteristic features associated with OA.
Fig.1 (A) cholesterol distribution in OA ACCs is higher compared to nor-
mal. (B) Cholesterol treatment induce oxidative stress environment
derived from abnormal mitochondrial function. (C) Cholesterol treatment
challenge cartilage haemostasis.
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RESVERATROL REGULATES THE WNT/ß-CATENIN PATHWAY IN
HUMAN OSTEOARTHRITIS OSTEOBLASTS
E. Abed, A. Delalandre, J-P. Pelletier, J. Martel-Pelletier, D. Lajeunesse.
CRCHUM, Montreal, QC, Canada
Purpose: Clinical and in vitro studies suggest that subchondral bone
sclerosis due to abnormal osteoblasts (Ob) is involved in the pro-
gression and/or onset of osteoarthritis (OA). Human Ob isolated from
sclerotic subchondral OA bone tissue show an altered phenotype, a
decreased canonical Wnt/ß-catenin signaling pathway (cWnt), and a
reduced mineralization in vitro, alterations linked with an abnormal
response to BMP-2. Recent studies have shown an association between
dietary polyphenols and the prevention of OA. Resveratrol (RSV) is a
polyphenolic phytoestrogen that activates Sirtuin 1, which we pre-
viously showed to be reduced in OA Ob. RSV also stimulates Ob differ-
entiation and may have a positive effect on cartilage protection. RSV
regulates the cWnt pathway in different cell systems and stimulates
BMP-2 expression in human Ob, however, the role of RSV and its effect
in OA Ob remains unknown. Here we investigated the role of RSV in OA
Ob and if it is responsible for their altered response to BMP-2.
Methods: We prepared primary human subchondral Ob using the
sclerotic medial portion of the tibial plateaus of OA patients undergoing
total knee arthroplasty, or from tibial plateaus of normal individuals at
autopsy. The expression of genes was evaluated by qRT-PCR and the
protein production by Western blot analysis. Alkaline phosphatase
activity (ALPase) and osteocalcin release (OC) were measured by
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S159substrate hydrolysis and EIA respectively. The cWnt pathway was
evaluated using two approaches: 1) target gene expression was meas-
ured using the TOPﬂash TCF/lef luciferase reporter assay, and 2) intra-
cellular signaling partners b-catenin and phospho b-catenin levels were
evaluated by Western blot analysis. Mineralization in response to RSV
was evaluated by Alizarin red staining.
Results: OA Ob showed an increased alkaline phosphatase activity and
osteocalcin release that were partly corrected in presence of increasing
doses of RSV. RSV had little effect on cell proliferation and only slightly
affected the Bax/Bcl2 ratio, an indicator of cell survival. The expression
of Runx2/Cbfa1 and PPARgwere not affected by increasing doses of RSV.
However, although it did not affect Sirtuin1 expression, RSV reduced
the expression of leptin. Moreover, Wnt3a alone increased b-catenin
levels and cWnt signaling activity, and both parameters were further
increased by RSV treatment. The BMP-2-dependent mineralization of
OA Ob, which is also reduced compared to normal, was partially
restored by RSV treatment as detected by alizarin red staining.
Conclusions: These data indicate that RSV can promote the Wnt/b-
catenin signaling pathway which is altered OA Ob. This last situation
could explain the role of RSV on alkaline phosphatase activity, osteo-
calcin release, and in vitro mineralization which are all altered in these
cells.
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ALTERATIONS OF THE NON-CANONICAL WNT/PKC PATHWAY IN
HUMAN OSTEOARTHRITIS OSTEOBLASTS
E. Abed, V. Siwing, X. Martineau, A. Delalandre, D. Lajeunesse. CRCHUM,
Montreal, QC, Canada
Purpose: Clinical and in vitro studies suggest that subchondral bone
sclerosis due to abnormal osteoblasts (Ob) is involved in the pro-
gression and/or onset of osteoarthritis (OA). Human Ob isolated from
sclerotic subchondral OA bone tissue show an altered phenotype, a
decreased canonical Wnt/ß-catenin signaling pathway (cWnt), and a
reduced mineralization in vitro, alterations linked with an abnormal
response to BMP-2. Besides the cWnt pathway, at least two non-can-
onical signaling pathways, the Wnt/PKC and Wnt/PCP pathway have
been described. However, there are no reports of either pathway in OA
Ob. TheWnt/PKC pathway is activated after a non-canonical Wnt ligand
such asWnt5a triggers a leucine-rich G-coupled protein receptor (LGR),
typically LGR4 or LGR5 in osteoblasts. This then drives the phosphor-
ylation of PKC (phosphoPKC), and downstream signaling targets. Here,
we studied if alterations of the Wnt/PKC pathway could be observed in
OA Ob.
Methods: We prepared primary human subchondral Ob using the
sclerotic medial portion of the tibial plateaus of OA patients undergoing
total knee arthroplasty, or from tibial plateaus of normal individuals at
autopsy. The expression of genes involved inWnt/PKC was evaluated by
qRT-PCR and the protein production by Western blot analysis. Alkaline
phosphatase activity (ALPase) and osteocalcin release (OC) were
measured by substrate hydrolysis and EIA respectively. The Wnt/PKC
and JNK pathways were evaluated using Western blot analysis of PKC,
phosphoPKC, JNK and phosphoJNK.
Results: OA Ob showed an increased alkaline phosphatase activity and
osteocalcin release. The expression of Wnt5a was increased in OA Ob
compared to normal. The expression of LGR4 and LGR5 was detected in
both normal and OA Ob, however, although the expression of LGR4 was
only slightly increased in OA Ob, the expression of LGR5 was sig-
niﬁcantly increased in these cells. Moreover, Wnt5a directly stimulated
the expression of LGR5 both at the mRNA level and protein level.
However, Wnt5a did not stimulate the expression of LGR4. Wnt5a
increased the expression of phosphoPKC without altering PKC levels,
and it also stimulated the phosphorylation of JNK.
Conclusions: These data indicate that Wnt5a, which is increased in OA
Ob, can directly increase the expression of LGR5 which in turn stim-
ulates the Wnt/PKC and JNK pathways. The exact role of the non-can-
onical pathway in OA still remains to be determined.
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ENDOGLIN REGULATES TRANSFORMING GROWTH FACTOR-BETA
SIGNALING AND CHONDROCYTE FUNCTION
Y. Chi y, K. Finnson y, A. Philip y, M. Letarte z, M. Kapoor x. yMcGill Univ.,
Montreal, QC, Canada; zUniv. of Toronto, Toronto, ON, Canada; xUniv. of
Montreal, Montreal, QC, CanadaTransforming growth factor-beta (TGF-b) plays a critical role in main-
taining integrity of articular cartilage by promoting synthesis of
extracellular matrix (ECM) proteins such as type II collagen. Dysregu-
lation of TGF-b action results in abnormal cartilage function which
eventually contributes to chronic degenerative joint disorders such as
osteoarthritis (OA).
Purpose: We have previously shown that chondrocytes express endo-
glin, a TGF-b co-receptor, and that endoglin inhibits TGF-b signaling and
decreases type II collagen production in chondrocytes. In addition, we
have shown that endoglin’s expression is upregulated in OA as com-
pared normal human cartilage. These results indicate that endoglin is a
regulator of TGF-b action and ECM turnover in chondrocytes and sug-
gest that endoglin overexpression may promote OA-like phenotype in
chondrocytes. In the current study, we examined whether endoglin
regulates expressions of genes involved in cartilage homeostasis using a
mouse model.
Methods: We used endoglin heterozygous mice (HET) that lack one
endoglin allele since endoglin null mice are embryonically lethal.
Murine chondrocytes were isolated from cartilages from these HET and
their wild-type littermates. Total RNAwas extracted and converted into
cDNA followed by gene expression analysis using a chondrogenesis
pathway speciﬁc PCRarray. Results: Our PCRarray data demonstrates
that HET chondrocytes show increased levels of TGF-b1 and Bone
Morphogenic Protein (BMP)-4 while HET chondrocytes show decreased
levels of cartilage oligomeric matrix protein (COMP) and Type X colla-
gen (n¼ 5). Other genes such as Cadherin-11 and Sox-9 showa decrease
in HET chondrocytes. Conclusion: Our ﬁndings that HET chondrocytes
show increased levels of TGF-b1 and BMP-4, two important cytokines
for ECM maintenance, support our previous in vitro data that endoglin
negatively regulates TGF-b1 action. The HET chondrocytes display
decreased levels of COMP and type X collagen whose expression levels
are known to be increased in OA cartilage. Altogether, these results
support the notion that presence of endoglin negatively regulates TGF-b
action in cartilage. Determining the mechanism by which endoglin
regulates TGF-b signaling and ECM synthesis in chondrocytes in vivo
may provide a basis for the development of novel therapeutic
approaches to improve cartilage integrity.Chondrocyte Biology
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g-SECRETASE INHIBITOR DAPT PREVENTS OSTEOARTHRITIS
PROGRESSION IN MOUSE EXPERIMENTAL MODEL BY INHIBITION
OF NOTCH SIGNALING
Y. Hosaka y, S. Sugita y, K. Okada y, S. Tanaka y, H. Kawaguchi y,z,
T. Saito y,x. y Sensory and Motor System Med., The Univ. of Tokyo, Tokyo,
Japan; z Spine Ctr., Tokyo Kosei Nenkin Hosp., Tokyo, Japan; xBone and
Cartilage Regenerative Med., Faculty of Med., The Univ. of Tokyo, Tokyo,
Japan
Purpose: Notch is a single-pass transmembrane cell surface receptor
which plays a crucial role in cell fate assignment by regulating differ-
entiation and apoptosis during embryogenesis and postnatal develop-
ment. The Notch signaling pathway is regulated by several molecules:
Notch ligands (Delta-like1, 3, 4, or Jagged1 and -2), Notch receptors
(Notch1-4), a transcriptional effector Rbpj, and target transcription factor
Hes/Hey family members. The signaling is initiated by the Notch ligands
on the cell surface binding to the Notch receptors on the adjacent cells.
Upon binding, the Notch receptor is cleaved by proteinases including a
disintegrin and metalloproteinase (Adam), and subsequently by the g-
secretase complex allowing the Notch intracellular domain (ICD) to be
released into the cytoplasm. Then, the ICD translocates to the nucleus and
binds to Rbpj, forming a transcriptional activator and inducing target
genes such as the Hes/Hey family. Previously, we reported the induction
of markers of hypertrophic chondrocytes likeMmp13 and Vegfa by Notch
ICD overexpression in cultured chondrocytes, and the involvement of the
Rbpj-dependent Notch signaling in the endochondral ossiﬁcation process
during skeletal growth and osteoarthritis (OA) development using Rbpj
conditional knockout mice. Here we investigated therapeutic effects of
DAPT (N-[N-(3,5-diﬂurophenylacetate)-L-alanyl]-(S)-phenylglycine t-
butyl ester), a representative g-secretase inhibitor, using a mouse
experimental model.
Methods: We obtained primary articular chondrocytes from 5-day-old
mouse knee joints, and cultured them with or without DAPT (Calbio-
chem) in a differentiation medium (DMEM containing 10% FBS, 10 mM
